Understanding the complex microenvironment in oral cancer: the contribution of the Faculty of Dentistry, University of Otago over the last 100 years

References

• Alkharusi A. 2017. Lymph nodes as a pre-metastatic niche for oral squamous cell carcinoma [PhD dissertation]. University of Otago.
   Google Scholar
• Allavena P, Sica A, Solinas G, Porta C, Mantovani A. 2008. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 66(1):1–9.
   PubMed Web of Science ®Google Scholar
• Allsobrook OFL. 2014. Angiogenic factors in oral squamous cell carcinoma [DClinDent thesis]. University of Otago.
   Google Scholar
• Avadhani A. 2015. Role of interleukin 17 in progression of oral squamous cell carcinoma [PhD dissertation]. University of Otago.
   Google Scholar
• Avadhani AV, Milne T, Seymour GJ, Rich AM. 2015. Interleukin-17 induces matrix metalloproteinase activation and invasion in oral cancer. J Dent Res. 94:2331200.
   Google Scholar
• Avadhani A, Parachuru VPB, Milne T, Seymour GJ, Rich AM. 2017. Multiple cells express interleukin 17 in oral squamous cell carcinoma. J Oral Pathol Med. 46(1):39–45.
   PubMed Web of Science ®Google Scholar
• Aziz M. 2019. Exosomes in oral cancer [unpublished PhD dissertation]. University of Otago.
   Google Scholar
• Beggs KT, Holmes AR, Cannon RD, Rich AM. 2004. Detection of Candida albicans mRNA in archival histopathology samples by reverse transcription-PCR. J Clin Microbiol. 42(5):2275–2278.
   PubMed Web of Science ®Google Scholar
• Binnie WH. 1976. Epidemiology and etiology of oral cancer in Britain. Proc R Soc Med. 69(10):737–740.
   PubMedGoogle Scholar
• Blasco MA, Svider PF, Raza SN, Jacobs JR, Folbe AJ, Saraf P, Eloy JA, Barades S, Fribley AM. 2017. Systemic therapy for head and neck squamous cell carcinoma: historical perspectives and recent breakthroughs. Laryngoscope. 127(11):2565–2569.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Mackay CR, O’Shea JJ, Stockinger B. 2009. The functional plasticity of T cell subsets. Nat Rev Immunol. 9(11):811–816.
   PubMed Web of Science ®Google Scholar
• Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, Schiff B, Owen RP, Smith J, Sarta C, et al. 2010. Validation of the histologic risk in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol. 34(5):676–688.
   PubMed Web of Science ®Google Scholar
• Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY. 2005. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 29(2):167–178.
   PubMed Web of Science ®Google Scholar
• Bryne M. 1998. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis. 4(2):70–77.
   PubMedGoogle Scholar
• Cassetta L, Pollard JW. 2018. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 17(12):887–904.
   PubMed Web of Science ®Google Scholar
• Chutipongpisit K. 2016. Lymphangiogenesis in oral squamous cell carcinoma [DClinDent thesis]. University of Otago.
   Google Scholar
• Cochaud S, Giustiniani J, Thomas C, Laprevotte E, Garbar C, Savoye M, Cure H, Mascaux C, Alberici G, Bonnefoy N, et al. 2013. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Sci Rep. 3:3456.
   PubMed Web of Science ®Google Scholar
• Cueni LN, Hegyi I, Shin JW, Albinger-Hegyi A, Gruber S, Kunstfeld R, Moch H, Detmar M. 2010. Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin. Am J Pathol. 177(2):1004–1016.
   PubMed Web of Science ®Google Scholar
• De Henau O, Rausch M, Winkler D, Campesato LF, Liu C, Cymerman DH, Budhu S, Ghosh A, Pink M, Tchaicha J, et al. 2016. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells. Nature. 539(7629):443–447.
   PubMed Web of Science ®Google Scholar
• Derbal Y. 2018. The adaptive complexity of cancer. Biomed Res Int. DOI:10.1155/2018/5837235.
   PubMed Web of Science ®Google Scholar
• Doglioni G, Parik S, Fendt S-M. 2019. Interactions in the (pre) metastatic niche support metastasis formation. Front Oncol. DOI:10.3389/fonc.2019.00219.
   PubMed Web of Science ®Google Scholar
• Duffield J. 2003. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. 104(1):27–38.
   PubMed Web of Science ®Google Scholar
• Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y, Lui VWY, Xia J, Cheng B, Wang Z. 2017. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer. 17(1):375.
   PubMed Web of Science ®Google Scholar
• Ferguson JW. 1977. Studies on the progression of experimental pre-malignant lesions [Masters of Dental Surgery thesis]. University of Otago.
   Google Scholar
• Ferguson JW. 1985. A light and transmission electron microscope study of normal mucosa and chemically induced premalignant and malignant lesions in hamster cheek pouch [PhD dissertation]. University of Otago.
   Google Scholar
• Ferguson JW, McMillan MD, Smillie AC. 1991. Ultrastructural examination of experimentally induced premalignant lesions. Int J Oral Maxillofac Surg. 20(2):112–118.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. 2018. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer. https://gco.iarc.fr/today.
   Google Scholar
• Fish WD. 1950. The future of dentistry. New Zeal Dent J. 40:144.
   Google Scholar
• Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem. 267(16):10931–10934.
   PubMed Web of Science ®Google Scholar
• Gavidi RO, Rich AM, Cox B, King T. 2014. Comparing the occurrence of oral squamous cell carcinoma in New Zealand and the Fiji islands from 2000–2010. Int J Cancer Res. 48(1):1212–1225.
   Google Scholar
• Ghani WMN, Doss JG, Jamaluddin M, Kamaruzaman D, Zain RB. 2013. Oral cancer awareness and its determinants among a selected Malaysian population. Asian Pacific J Cancer Prevent. 14(3):1957–1963.
   PubMedGoogle Scholar
• Guo Y, Ji X, Liu J, Fan D, Zhou Q, Chen C, Wang W, Wang G, Wang H, Yuan W, et al. 2019. Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer. 18(1):39.
   PubMed Web of Science ®Google Scholar
• Guo M, Rabin BS, Johnson JT, Paradis IL. 1987. Lymphocyte phenotypes at tumor margins in patients with head and neck cancer. Head Neck Surg. 9(5):265–271.
   PubMedGoogle Scholar
• Ho C-C, Liao W-Y, Wang C-Y, Lu Y-H, Huang H-Y, Chen H-Y, Chan W-K, Chen H-W, Yang P-C. 2008. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med. 177(7):763–770.
   PubMed Web of Science ®Google Scholar
• Hsu S, Chiu C, Dahms H, Chou C, Cheng C, Chang W, Cheng K, Wang H, Lin I. 2019. Unfolded protein response (UPR) in survival, dormancy, immunosuppression, metastasis, and treatments of cancer cells. Int J Mol Sci. 20(10):2518.
   PubMed Web of Science ®Google Scholar
• Hussaini HM. 2013. Immune responses in primary oral squamous cell carcinoma and lymph node metastasis [PhD dissertation]. University of Otago.
   Google Scholar
• Hussaini HM, Parachuru VPB, Seymour GJ, Rich AM. 2017. Forkhead box-P3+ regulatory T cells and toll-like receptor 2 co-expression in oral squamous cell carcinoma. Acta Histochem. 119(3):205–210.
   PubMed Web of Science ®Google Scholar
• Ibrahim NR. 2017. Lymphangiogenesis in metastatic lymph nodes of oral squamous cell carcinoma [DClinDent Dissertation]. University of Otago.
   Google Scholar
• Kaidar-Person O, Gil Z, Billan S. 2018. Precision medicine in head and neck cancer. Drug Resist Updates. DOI:10.1016/j.drup.2018.09.001.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan Y-H, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L. 2008. Podoplanin: A novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol. 26(3):354–360.
   PubMed Web of Science ®Google Scholar
• Lopes V, Murray P, Williams H, Woodman C, Watkinson J, Robinson M. 2011. Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus. Oral Oncol. 47(8):698–701.
   PubMed Web of Science ®Google Scholar
• MacDonald VP. 1924. The mouth in health and disease. New Zeal Dent J. 20:155.
   Google Scholar
• MacPherson LMD. 2018. Raising awareness of oral cancer from a public and health professional perspective. Br Dent J. 225(9):809–814.
   PubMed Web of Science ®Google Scholar
• Male D, Brostoff J, Roth D, Roitt I. 2006. Immunology. 7th ed. Orlando (FL): Mosby. p. 145–161.
   Google Scholar
• Maleki S, Schlecht NF, Keller G, Diaz J, Moss J, Prystowsky MB, Macian F, Brandwein-Gensler M. 2011. Lymphocytic host response to oral squamous cell carcinoma: an adaptive T-cell response at the tumor interface. Head Neck Patho.l. 5(2):117–122.
   PubMedGoogle Scholar
• Mantovani A, Ming WJ, Balotta C, Abdeljalil B, Bottazzi B. 1986. Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochim Biophys Acta. 865(1):59–67.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25(12):677–686.
   PubMed Web of Science ®Google Scholar
• Martin-Villar E, Scholl FG, Gamallo C, Yurita MM, Munoz-Guerra M, Cruces J, Quintanilla M. 2005. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrance mucin induced in oral squamous cell carcinomas. Int J Cancer. 113(6):899–910.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Sica A, Mantovani A, Locati M. 2008. Macrophage activation and polarization. Front Biosci. 13:453–461.
   PubMed Web of Science ®Google Scholar
• McCluskey J. 2011. Update on T-cell immunity: Implications for tumor immunology. Asia Pac J Clin Oncol. 7:3–8.
   Web of Science ®Google Scholar
• McMillan MD. 1988. There's more to dentistry than teeth and gums: for instance, oral cancer. Inaugural Professorial Lecture (IPL). Hocken Library, University of Otago.
   Google Scholar
• McMillan MD, Smillie AC. 1996. Scanning electron microscopy of dimethylbenz-anthracene-treated hamster cheek pouch. J Oral Pathol Med. 25(1):14–19.
   PubMed Web of Science ®Google Scholar
• McMillan MD, Smith CJ, Ramirez V. 1994. The effect of intraperitoneal N-methyl-N-nitrosurea on hamster palatal mucosa. Arch Oral Biol. 39(6):519–528.
   PubMed Web of Science ®Google Scholar
• Meehan K, Vella LJ. 2016. The contribution of tumour-derived exosoms to the hallmarks of cancer. Crit Rev Clin Lab Sci. 53(2):121–131.
   PubMed Web of Science ®Google Scholar
• Mei Y, Zhang P, Zuo H, Clark D, Xia R, Li J, Liu Z, Mao L. 2014. Ebp1 activates podoplanin expression and contributes to oral tumorigenesis. Oncogene. 33(29):3839–3850.
   PubMed Web of Science ®Google Scholar
• Ministry of Health New Zealand. 2016. New cancer registrations 2016. https://www.health.govt.nz/publication/new-cancer-registrations-2016.
   Google Scholar
• Ministry of Health New Zealand. 2019. Selected cancers 2015, 2016–2017. https://www.health.govt.nz/publication/selected-cancers-2015-2016-2017.
   Google Scholar
• Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8(12):958–969.
   PubMed Web of Science ®Google Scholar
• Ng LK, Rich AM, Hussaini HM, Thomson WM, Fisher AL, Horne LS, Seymour GJ. 2011. Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma. Brit J Cancer. 104(3):460–463.
   PubMed Web of Science ®Google Scholar
• Oble DA, Loewe R, Yu P, Mihm MC. 2009. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun. 9:3.
   PubMedGoogle Scholar
• O’Higgins C, Ward FJ, Abu Eid R. 2018. Deciphering the role of regulatory CD4 T cells in oral and oropharyngeal cancer: a systematic review. Front Oncol. 8:442.
   PubMed Web of Science ®Google Scholar
• Pathria P, Louis TL, Varner JA. 2019. Targeting tumor-associated macrophages in cancer. Trends Immunol. 40(4):310–327.
   PubMed Web of Science ®Google Scholar
• Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, et al. 2017. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 17(5):302–317.
   PubMed Web of Science ®Google Scholar
• Pickerill HP. 1912. Stomatology in general practice. London: Oxford Medical Publication.
   Google Scholar
• Pinto ML, Rios E, Durães C, Ribeiro R, Machado JC, Mantovani A, Barbosa MA, Carneiro F, Oliveira MJ. 2019. The two faces of tumor-associated macrophages and their clinical significance in colorectal cancer. Front Immunol. 10:1875.
   PubMed Web of Science ®Google Scholar
• Punt S, Fleuren GJ, Kritikou E, Lubberts E, Trimbos JB, Jordanova ES, Gorter A. 2015. Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer. Oncoimmunol. 4:e984539.
   PubMed Web of Science ®Google Scholar
• Rajjoub S, Basha SR, Einhorn E, Cohen MC, Marvel DM, Sewell DA. 2007. Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J. 86(8):506–511.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. 2006. Inflammatory chemokines in cancer growth and progression. Eur J Cancer. 42(6):760–767.
   PubMed Web of Science ®Google Scholar
• Ruivo CF, Adem B, Silva M, Meio SA. 2017. The biology of cancer exosomes: insights and new perspectives. Cancer Res. 77(23):6480–6488.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 186(7):3808–3821.
   Google Scholar
• Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. 2005. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cells tumors. Am J Pathol. 166(3):913–921.
   PubMed Web of Science ®Google Scholar
• Schroff WD. 1954. The value of simple aids to diagnosis. New Zeal Dent J. 50:102.
   Google Scholar
• Seo B. 2019. ER stress and UPR in oral cancer [PhD dissertation]. University of Otago.
   Google Scholar
• Shearer BH, Jenkinson HF, McMillan MD. 1994. Changes in cytokeratins following treatment of hamster cheek pouch epithelia with hyperplastic or neoplastic agents. J Oral Pathol Med. 23(4):149–155.
   PubMed Web of Science ®Google Scholar
• Shearer BH, McMillan MD, Jenkinson HF. 1991. Comparison of the effects of four hyperplastic agents on hamster cheek pouch mucosa. J. Biol. Buccale. 19(4):315–318.
   PubMedGoogle Scholar
• Shearer BH, McMillan MD, Jenkinson HF. 1997. Differential expression of type 1 cytokeratins in hamster cheek pouch epithelium following treatment with dimethylbenzanthracene. J Oral Pathol Med. 26(10):470–476.
   Web of Science ®Google Scholar
• Shen K, Johnson D, Vessey D, McGuckin M, Gobe G. 2018. Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies. Cell Stress Chaperones. 23(3):317–334.
   PubMed Web of Science ®Google Scholar
• Snyderman CH, Heo DS, Johnson JT, D’Amico F, Barnes L, Whiteside TL. 1991. Functional and phenotypic analysis of lymphocytes in head and neck cancer. Arch Otolaryngol Head Neck Surg. 117(8):899–905.
   PubMedGoogle Scholar
• Strauss L, Bergmann C, Whiteside TL. 2009. Human circulating CD4 + CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J. Immunol. 182(3):1469–1480.
   PubMed Web of Science ®Google Scholar
• Symes GC, McMillan MD, Smillie AC, Boyd NM. 1995. Structure of hamster palatal gingiva and intermolar mucosa after intraperitoneal dosing with N-methyl-N-nitrosourea: a scanning electron microscope study. J Comparat Pathol. 112(4):403–415.
   PubMed Web of Science ®Google Scholar
• Tauati-Williams E. 2019. Investigation of the presence of human papillomavirus in verrucal-papillary lesions of the oral cavity and comparison of viral detection methods [DClinDent (Oral Pathology) thesis]. University of Otago.
   Google Scholar
• Tsuneki M, Yamazaki M, Maruyama S, Cheng J, Saku T. 2013. Podoplanin-mediated cell adhesion through extracellular matrix in oral squamous cell carcinoma. Lab Invest. 93(8):921–932.
   PubMed Web of Science ®Google Scholar
• Ugorski M, Dziegiel P, Suchanski J. 2016. Podoplanin-a small glycoprotein with many faces. Am J Cancer Res. 6(2):370–386.
   PubMed Web of Science ®Google Scholar
• Uppaluri R, Dunn GP, Lewis JS. 2008. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun. 8:16.
   PubMedGoogle Scholar
• Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9(6):654–659.
   PubMed Web of Science ®Google Scholar
• Wado-Ohno M, Ito T, Furue M. 2019. Adjuvant therapy for melanoma. Curr Treat Options Oncol. 20(8):63.
   PubMed Web of Science ®Google Scholar
• Wanebo HJ. 1979. Immunobiology of head and neck cancer: basic concepts. Head Neck Surg. 2(1):42–55.
   PubMedGoogle Scholar
• Warnakulasuriya S. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45(4–5):309–316.
   PubMed Web of Science ®Google Scholar
• Wei SC, Duffy CR, Allison JP. 2018. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 8(9):1069–1086.
   PubMed Web of Science ®Google Scholar
• Wendler F, Bota-Rabassedas N, Franch-Marro X. 2013. Cancer becomes wasteful: emerging roles of exosomes in cell-fate determination. J Extracell Vesicles. 2. DOI:10.3402/jev.v2i0.22390.
   PubMedGoogle Scholar
• Whiteside TL. 2006. The role of immune cells in the tumor microenvironment. Cancer Treat Res. 130:103–124.
   PubMedGoogle Scholar
• Wolf GT, Hudson JL, Peterson KA, Miller HL, McClatchey KD. 1986. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol Head Neck Surg. 95(2):142–152.
   PubMed Web of Science ®Google Scholar
• Yakin M, Gavidi O, Cox B, Rich AM. 2017. Oral cancer risk factors in New Zealand. New Zealand Med J. 130(1451):30–38.
   PubMed Web of Science ®Google Scholar
• Yakin M, Seo B, Hussaini HM, Rich AM, Hunter K. 2019a. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials. Aust Dent J. 64(1):11–18.
   PubMed Web of Science ®Google Scholar
• Yakin M, Seo B, Rich AM. 2019b. Tunicamycin-induced endoplasmic reticulum stress up-regulates tumour-promoting cytokines in oral squamous cell carcinoma. Cytokine. 120:1390–1143.
   Web of Science ®Google Scholar
• Yamamoto M, Kikuchi H, Ohta M, Kawabata T, Hiramatsu Y, Kondo K, Baba M, Kamiya K, Tanaka K, Kitagawa M, et al. 2008. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res. 68(23):9754–9762.
   PubMed Web of Science ®Google Scholar
• Yu P, Fu Y-X. 2006. Tumor-infiltrating T lymphocytes: friends or foes? Lab. Invest. 86(3):231–245.
   PubMed Web of Science ®Google Scholar
• Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, Lee JJ, Mao L. 2006. Over-expression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer. 107(3):563–569.
   PubMed Web of Science ®Google Scholar
• Zain RB, Asthirajan V, Ghani WMN, Razak IA, Raja Latifah RJ, Ismail SM, Sallam AA, Bustam AZ, Rahman ZA, Hussien A, et al. 2013. An oral cancer biobank initiative: a platform for multidisciplinary research in a developing country. Cell Tissue Bank. 14(1):45–52.
   PubMed Web of Science ®Google Scholar
• Zancope E, Costa NL, Junqueira-Kipnis AP, Valadares MC, Silva TA, Leles CR, Mendonca EF, Batista AC, et al. 2010. Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med. 39(2):162–167.
   PubMed Web of Science ®Google Scholar
• Zhu X-D, Zhang J-B, Zhuang P-Y, Zhu H-G, Zhang W, Xiong Y-Q, Wu W-Z, Wang L, Tang Z-Y, Sun H-C. 2008. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol. 26(16):2707–2716.
   PubMed Web of Science ®Google Scholar